Latest Breaking News On - Meredith kaya - Page 1 : comparemela.com

Positive One-Year Data from Phase 2 Study of Pegcetacoplan in Post-Transplant Recurrence of C3G and IC-MPGN Presented as Late-Breaker at ERA Congress

Positive One-Year Data from Phase 2 Study of Pegcetacoplan in Post-Transplant Recurrence of C3G and IC-MPGN Presented as Late-Breaker at ERA Congress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesLissa pavlukMeredith kayaFadi fakhouriLydia abad franchCaroline baumalExchange commissionApellis pharmaceuticals incSobi investor relations teamEuropean renal associationExchange commission onNational institute of healthEuropean unionNorth americaMiddle eastForward looking statement

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) Q1 2024 Earnings Call Transcript

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesTim sullivanRaymond jamesPhil ferroneTazeen ahmadCedric francoisAnupam ramaYigal nochomovitzJon millerSteve seedhouseCaroline baumalPriyanka groverJonathan millerMadam townsendSalveen richterMeredith kaya

Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results

Generated $172.3 million in 1Q 2024 revenues, including $163.1 million in U.S. net product sales $137.5 million for SYFOVRE® $25.6 million for EMPAVELI® Anticipates CHMP opinion for pegcetacoplan.

United statesPhilip ferroneMeredith kayaLissa pavlukCedric francoisExchange commission onApellis pharmaceuticals incAdvisory committee on immunization practicesEuropean unionExchange commissionEuropean medicines agencyNocturnal hemoglobinuriaSenior convertible notesSafety informationRetinal detachmentsRetinal vascular occlusion

Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America Securities Healthcare Conference

WALTHAM, Mass., May 06, 2024 Apellis Pharmaceuticals, Inc. today announced that the company will host a fireside chat at the Bank of America Securities Healthcare Conference on Tuesday, May.

United statesMeredith kayaApellis pharmaceuticalsApellis pharmaceuticals incAmerica securities healthcare conference

Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America Securities Healthcare

WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the Bank of America Securities Healthcare

United statesMeredith kayaApellis pharmaceuticals incApellis pharmaceuticalsAmerica securities healthcare conference